pennies to thousands cadidatewatch for 200 day
volume and other indicators good
good j hook pattern
read our book
chapter 5 for an extensive list of indicators
tune into our channel on utube
like us on face book
Biotechnology
!BIOTECH WARNING!Big short potential if IBB doesn't break back into the wedge tomorrow (2/11). Ill be looking to add more LABD by the end of the week if we don't see a bounce. This could be a big one!
Biotech tests very important support zoneThe Biotech bubble bursting hits Nasdaq and makes it the weaker link in the indices chain.
It all began when $IBB broke below 360$, closing below its Fast SMA line, providing the bearish signal by breaking down the weekly uptrend line (see point 1)
August's declines lead $IBB to re-test another weekly uptrend line and the 300$ support zone - This created a rally back towards 360$ that ended when the price was rejected by the 360 structure and the Fast SMA line that flipped roles to resistance.
Now, three week's later, $IBB is re-testing the 300$ (currently inside the zone). It is also re-testing the same uptrend that helped it during August.
That is a critical zone for Biotech. The next support zone is near 260$ and below it, the 200 weeks MA waits near 230$.
If $IBB will manage to find the necessary support inside 280-300$ again, it could lead to a rally towards its 50 weeks MA line that should turn to resistance now.
A close above 300$ could be a bullish confirmation signal that we are heading there.
Follow me on TradingView
Follow my blog: marketzone.tumblr.com
Subscribe to my newsletters: goo.gl
Short biotechnology again near trend line resistance Biotech bubble has burst.
Every rallies are to be sold, and despite the euphoria/new highs in S&P and Nasdaq have barely registered a decent retracement in the biotech sector..
Here's a larger picture of how far biotechs have went since 2008:
The uptrend in S&P is limited, and it will only be a matter of time before it collapses off this rising wedge. However it is also risky to go against Janet Yellen (FED) with unlimited cash in its balance sheet. A short on a specific sector would be a much safer bet.
-------------------
I'm long on ZBIO (3x short biotech ETF) at 22.51, with a target around $30~40.
#Nasdaq #Biotech It ought to correct overboughtIt ought to correct overbought Nasdaq Biotechnology Index:
The Nasdaq Biotech index has grown about 50 percent since Yellen's valuation comments. Superarando por mucho el desempeño de los indices composite y S&P500, this boom is due primarily to the pharmaceutical companies who have monopolized the attention of investors the past few months, beyond the debate of whether exist a bubble formation the Nasdaq Biotechnology Index It ought to correct their overbought at least 6% as it has done in later months
www.bloomberg.com
The Seven Reason I Bought GILDI Bought GILD for seven reasons:
(1) Head and Shoulders Pattern (60 min)
(2) Horizontal Support from Left Shoulder ($102.72)
(3) 61.8% Fib level Support @ $102.75
(4) Descending Trend line Support
(5) Long-wicked Hammer found Support at Trend line
(6) Weekly Uptrend
(7) Selling Climax in February 2015
(8) The risk/reward potential is favorable. My reward is based on a daily and weekly chart. So, It is approx. $117.
-ScienceEvolution
